tiprankstipranks
Advertisement
Advertisement

PRQR Stock Latest News

ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
Company AnnouncementsProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
3d ago
6K
PRQR
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
PremiumRatings
ProQR: Buy Rating Reiterated as Axiomer Pipeline Progress and Upcoming Catalysts Support Unchanged $12 Price Target
23d ago
PRQR
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
PremiumCompany Announcements
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances
24d ago
6K
PRQR
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
PremiumCompany Announcements
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
24d ago
6K
PRQR
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
PremiumCompany Announcements
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders
1M ago
6K
PRQR
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase
PremiumCompany AnnouncementsProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase
1M ago
6K
PRQR
ProQR Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
ProQR Therapeutics management to meet with Cantor Fitzgerald
2M ago
PRQR
ProQR Therapeutics management to meet with Oppenheimer
Premium
The Fly
ProQR Therapeutics management to meet with Oppenheimer
2M ago
PRQR
ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
PremiumCompany Announcements
ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs
2M ago
6K
PRQR
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
PremiumCompany Announcements
ProQR Partners with Ginkgo Bioworks, Launches AI Advisory Board to Drive Axiomer RNA Drug Discovery
2M ago
6K
PRQR
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
2M ago
PRQR
SERV
ProQR Sets April 8 Virtual Investor Event to Spotlight Axiomer RNA Editing Pipeline
PremiumCompany Announcements
ProQR Sets April 8 Virtual Investor Event to Spotlight Axiomer RNA Editing Pipeline
2M ago
6K
PRQR
ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty
PremiumCompany AnnouncementsProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty
3M ago
PRQR
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027
Premium
Company Announcements
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027
3M ago
6K
PRQR
ProQR Therapeutics assumed with an Outperform at Oppenheimer
Premium
The Fly
ProQR Therapeutics assumed with an Outperform at Oppenheimer
3M ago
PRQR
ProQR Therapeutics reports FY25 EPS (EUR 0.40) vs (EUR 0.32) last year
PremiumThe Fly
ProQR Therapeutics reports FY25 EPS (EUR 0.40) vs (EUR 0.32) last year
3M ago
PRQR
ProQR Therapeutics participates in a conf call hosted by Cantor Fitzgerald
PremiumThe Fly
ProQR Therapeutics participates in a conf call hosted by Cantor Fitzgerald
4M ago
PRQR
PRQR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PRQR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
PRQR
ProQR Therapeutics Plans Board Changes as Co-Founder and Director Exit at 2026 AGM
PremiumCompany Announcements
ProQR Therapeutics Plans Board Changes as Co-Founder and Director Exit at 2026 AGM
4M ago
6K
PRQR
ProQR Therapeutics directors Dinko Valerio, Alison Lawton to depart
PremiumThe FlyProQR Therapeutics directors Dinko Valerio, Alison Lawton to depart
4M ago
PRQR
ProQR Reports Positive AX-0810 Phase 1 Data, Advances Rett and MASH Candidates, and Outlines 2026 Pipeline Plans
Premium
Company Announcements
ProQR Reports Positive AX-0810 Phase 1 Data, Advances Rett and MASH Candidates, and Outlines 2026 Pipeline Plans
5M ago
6K
PRQR
ProQR announces initial safety, PK data from Phase 1 trial of AX-0810
Premium
The Fly
ProQR announces initial safety, PK data from Phase 1 trial of AX-0810
5M ago
LLY
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >